Influence of gag and pol regions on replication efficiency of a multidrug-resistant HIV-1 variant:: a systematic assessment

被引：0
|
作者：
Simon, V
Padte, N
Driver, I
Wang, NC
DiMascio, M
Markowitz, M
机构：
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA
[2] NIAID, NIH, Bethesda, MD 20892 USA
来源：
ANTIVIRAL THERAPY | 2003年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
77
引用
收藏
页码：U78 / U78
页数：1
相关论文
共 50 条
  • [41] Molecular cloning and replication characterization of a newly transmitted, dual-tropic, multidrug-resistant HIV-1 associated with rapid disease progression
    Mohri, H.
    Markowitz, M.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S99 - S99
  • [42] Novel determinants in HIV-1 gag regulate protease activity and viral fitness in a drug resistant variant
    Koch, S
    O'Brien, P
    Rose, S
    Pomeroy, S
    Dunn, B
    Sleasman, J
    Goodenow, M
    ANTIVIRAL THERAPY, 2005, 10 (04) : S179 - S179
  • [43] Enfurvitide prevents vertical transmission of multidrug-resistant HIV-1 in pregnancy but does not cross the placenta
    Brennan-Benson, P
    Pakianathan, M
    Rice, P
    Bonora, S
    Chakraborty, R
    Sharland, M
    Hay, P
    AIDS, 2006, 20 (02) : 297 - 299
  • [44] Wide-open 1.3 Å structure of a multidrug-resistant HIV-1 protease as a drug target
    Martin, P
    Vickrey, JF
    Proteasa, G
    Jimenez, YL
    Wawrzak, Z
    Winters, MA
    Merigan, TC
    Kovari, LC
    STRUCTURE, 2005, 13 (12) : 1887 - 1895
  • [45] Novel determinants in HIV-1 gag regulate protease activity and viral fitness in a drug resistant variant
    Koch, S
    O'Brien, P
    Rose, S
    Pomeroy, S
    Dunn, B
    Sleasman, J
    Goodenow, M
    ANTIVIRAL THERAPY, 2005, 10 : S179 - S179
  • [46] Survival of HIV-1 Infected Multidrug-Resistant Patients Recycling Enfuvirtide After a Previous Failure
    Cossarini, Francesca
    Galli, Laura
    Sagnelli, Caterina
    Cianotti, Nicola
    Hasson, Hamid
    Clementi, Massimo
    Soria, Alessandro
    Salpietro, Stefania
    Lazzarin, Adriano
    Castagna, Antonella
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (02) : 179 - 184
  • [47] Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection
    Deeks, SG
    Hoh, R
    Neilands, TB
    Liegler, T
    Aweeka, F
    Petropoulos, CJ
    Grant, RM
    Martin, JN
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (09): : 1537 - 1544
  • [48] CONVERGENT COMBINATION THERAPY CAN SELECT VIABLE MULTIDRUG-RESISTANT HIV-1 IN-VITRO
    LARDER, BA
    KELLAM, P
    KEMP, SD
    NATURE, 1993, 365 (6445) : 451 - 453
  • [49] A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection
    Coull, JJ
    Turner, D
    Melby, T
    Betts, MR
    Lanier, R
    Margolis, DM
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (05) : 423 - 434
  • [50] Inhibition of multidrug-resistant HIV-1 by interference with cellular S-adenosylmethionine decarboxylase activity
    Schaefer, Birgit
    Hauber, Ilona
    Bunk, Andrea
    Heukeshoven, Jochen
    Duesedau, Arne
    Bevec, Dorian
    Hauber, Joachim
    JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (06): : 740 - 750
12345